Myeloid Therapeutics
Gregory St. Louis is a Sr. Project Manager, CMC with experience in managing analytical outsourcing activities for clinical stage gene therapy products. With a background in analytical method development and strong inter-departmental relationships, St. Louis has worked in various scientific roles at companies like Voyager Therapeutics, Momenta Pharmaceuticals, and Millennium Pharmaceuticals. St. Louis holds a B.S. in Biology from the University of Massachusetts Amherst.
This person is not in any offices
Myeloid Therapeutics
Myeloid Therapeutics is an immunology company focused on combining biology insights with cutting-edge technologies to harness myeloid cells and eradicate cancer and other diseases.